Latest Publications

Share:

USPTO Tries to Address Public Misunderstandings Regarding Myriad-Mayo Guidance

The U.S. Patent and Trademark Office spent the entire afternoon session of today's biotechnology/chemical/pharmaceutical (BCP) customer partnership meeting focusing on the guidance memorandum for determining the subject...more

4/17/2014 - Biotechnology Myriad Patent-Eligible Subject Matter USPTO

Indiana Governor Signs Biosimilar Substitution Bill

On March 25, Indiana Governor Mike Pence signed legislation (Senate Bill 262) that will allow pharmacists in Indiana to substitute an interchangeable biosimilar product for a prescribed biological product if certain...more

4/11/2014 - Biosimilars FDA Healthcare Patents Pharmaceutical Pharmacies Prescription Drugs

House and Senate Bills Would Provide Incentive for Repurposing Old Biologics

Last month, Sen. Richard Blumenthal (D-CT) and Rep. Joaquin Castro (D-TX) introduced legislation in the Senate and House, respectively, that would extend the term of certain patents claiming a method of using a biological...more

4/10/2014 - Biologics Patent Reform Patents Pharmaceutical

GEN and FiercePharma Compile Lists of Top Selling Drugs for 2013

Earlier this month, Genetic Engineering & Biotechnology News released its list of the top 25 best-selling drugs worldwide for 2013. GEN's list, which the journal released on March 3 (see "The Top 25 Best-Selling Drugs of...more

3/27/2014 - Biotechnology Pharmaceutical Prescription Drugs

USPTO to Permit Delay in Meeting Certain Prioritized Examination Requirements

In an interim rule published in the Federal Register last week (79 Fed. Reg. 12386), the U.S. Patent and Trademark Office indicated that the time periods for meeting certain requirements for filing a request for Track I...more

3/13/2014 - Patent Examinations Patent Litigation Patents USPTO

USPTO Issues Guidance for Analyzing Subject Matter Eligibility of Claims Reciting Laws of Nature/Natural Principles, Natural...

Earlier today, in a memorandum issued to the Patent Examining Corps by Deputy Commissioner for Patent Examination Policy Andrew Hirshfeld, the U.S. Patent and Trademark Office implemented a new procedure for determining the...more

3/5/2014 - AMP v Myriad Mayo v. Prometheus Patent-Eligible Subject Matter SCOTUS USPTO

White House Seeks to Promote Transparency Concerning Patent Ownership

Last week, the Obama Administration announced "major progress on a series of initiatives designed to combat patent trolls and further strengthen our patent system and foster innovation" (see "The White House Releases Update...more

2/25/2014 - Patent Ownership Patent Reform Patent Trolls Patents Transparency

Democratic House Leadership Does Not Want TPP to Undermine Public Health

Last month, in a letter sent to the U.S. Trade Representative, Ambassador Michael Froman, five Representatives reiterated the importance of incorporating the 2007 Bipartisan Agreement on Trade Policy into the Trans-Pacific...more

2/13/2014 - Public Safety Trans-Pacific Partnership

Consumer Watchdog Replies to United States Brief on Standing Issue

In December, the Federal Circuit invited the United States to address the issue of whether Consumer Watchdog had Article III standing to pursue an appeal of a decision by the Board of Patent Appeals and Interferences...more

2/11/2014 - Article III Patent Trial and Appeal Board Patents Standing

United States Argues That Consumer Watchdog Lacks Standing to Appeal Board Decision on WARF Patent

In December, the Federal Circuit invited the United States to address the issue of whether Consumer Watchdog had Article III standing to pursue an appeal of a decision by the Board of Patent Appeals and Interferences...more

2/6/2014 - Article III Patents Standing

Consolidated Appropriations Act Provides for Public Access to Federal Research

Last month, President Obama signed the Consolidated Appropriations Act, 2014, which makes consolidated appropriations for the fiscal year ending September 30, 2014. One provision of the 639-page Act, which can be found in...more

2/5/2014 - Consolidated Appropriations Act Federal Budget Research Funding

USPTO Proposes Rules Changes to Require Identification in Applications and Patents of Attributable Owners

Last week, the U.S. Patent and Trademark Office published a notice of proposed rulemaking in the Federal Register (79 Fed. Reg. 4105), in which the Office proposed changes to the rules of practice that it claimed would...more

1/29/2014 - Patent Applications Patent Ownership Patents USPTO

Biotech Venture Funding Rebounded in 2013 After Strong Fourth Quarter

Earlier this month, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its MoneyTree Report on venture funding for 2013. The report,...more

1/27/2014 - Biotechnology Patents Pharmaceutical Venture Capital

More Q&A from Webinar on Top Patent Law Stories of 2013

On Tuesday, we presented a live webinar on the "Top Patent Law Stories of 2013." The webinar covered ten of the fourteen stories that made it onto Patent Docs seventh annual list of top biotech/pharma patent stories. Posts...more

1/24/2014 - 23andMe America Invents Act AMP v Myriad Biotechnology Bowman v Monsanto FTC v Actavis Innovation Act Life Sciences Monsanto Myriad Patent Infringement Patent Litigation Patent Reform Patent Trolls Patents Pharmaceutical SCOTUS

Novartis AG v. Lee (Fed. Cir. 2014)

In an opinion issued earlier today, the Federal Circuit affirmed a determination by the District Court for the District of Columbia that challenges of patent term adjustment (PTA) determinations by the U.S. Patent and...more

1/16/2014 - Novartis Patent Litigation Patent Term Adjustment Patent Terms Patents

USPTO Extends Missing Parts Pilot Program Once Again

In a Federal Register notice published last week (79 Fed. Reg. 642), the U.S. Patent and Trademark Office announced that the Extended Missing Parts Pilot Program that was implemented three years would be extended for another...more

1/15/2014

USPTO Releases Performance and Accountability Report for FY 2013

The U.S. Patent and Trademark Office recently released its Performance and Accountability Report for Fiscal Year (FY) 2013. As in last year's report, the most recent report notes that the Office's 2010-2015 Strategic Plan...more

1/10/2014 - Patent Applications Patents Transparency USPTO

FDA Approved 27 New Drugs in 2013

Last month, the U.S. Food and Drug Administration (FDA) announced that the agency approved 27 new drugs and biological products in 2013. According to the FDA release, the 27 new molecular entities (NMEs) that were approved...more

1/9/2014 - FDA Pharmaceutical Prescription Drugs

NAI & IPO Release List of Top 100 Universities Receiving Patents in 2012

Last month, the National Academy of Inventors (NAI) and the Intellectual Property Owners Association (IPO) published a list of the top 100 worldwide universities that received the most U.S. utility patents in 2012. The...more

1/8/2014 - Intellectual Property Owners Association Inventors Patents USPTO

Top Three Stories of 2013

Reflecting upon the events of the past twelve months, Patent Docs presents its seventh annual list of top biotech/pharma patent stories. For 2013, we identified fourteen stories that were covered on Patent Docs last year...more

1/6/2014 - America Invents Act AMP v Myriad Biotechnology Bowman v Monsanto DNA First-to-File First-to-Invent Genetic Materials Genetically Engineered Seed Human Genes Inventors Monsanto Patent Infringement Patent Litigation Patent Reform Patents Pharmaceutical SCOTUS

Top Stories of 2013: #4 to #6

Reflecting upon the events of the past twelve months, Patent Docs presents its seventh annual list of top biotech/pharma patent stories. For 2013, we identified fourteen stories that were covered on Patent Docs last year...more

1/3/2014 - Actavis Inc. America Invents Act Computer-Related Inventions FTC FTC v Actavis Patent Law Treaty Patent-Eligible Subject Matter Patents Reverse Payment Settlement Agreements SCOTUS USPTO

Top Stories of 2013: #7 to #10

Reflecting upon the events of the past twelve months, Patent Docs presents its seventh annual list of top biotech/pharma patent stories. For 2013, we identified fourteen stories that were covered on Patent Docs last year...more

1/2/2014 - Ambry Biotechnology BRCA DNA Human Genes Life Sciences Myriad Patent Litigation Patents Pharmaceutical

Top Stories of 2013: #11 to #14

Reflecting upon the events of the past twelve months, Patent Docs presents its seventh annual list of top biotech/pharma patent stories. For 2013, we identified fourteen stories that were covered on Patent Docs last year...more

1/2/2014 - 23andMe Biosimilars Biotechnology BPCIA Medtronic v Boston Scientific Patents Pharmaceutical Unified Patent Court

USPTO Issues Memo On Changes Pertaining To Patent Law Treaty

Last week, we reported on changes to the rules of practice made pursuant to title II of the Patent Law Treaties Implementation Act of 2012 (PLTIA), which was enacted on December 18, 2012, and which amended U.S. Patent Law to...more

12/27/2013 - Examiners Foreign Patent Applications Patent Applications Patents PLTIA Provisional Applications Trademarks

USPTO Issues Final Rule to Implement Patent Law Treaty -- Changes Take Effect December 18

On October 21, the U.S. Patent and Trademark Office issued a final rule (78 Fed. Reg. 62368) revising the rules of practice pursuant to title II of the Patent Law Treaties Implementation Act of 2012 (PLTIA), which amends U.S....more

12/17/2013 - Patent Applications Patents PLTIA USPTO

120 Results
|
View per page
Page: of 5